Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when its revenues moved up 2%.
Revenues increased by 2% annually to $7.4 billion in the final three months of fiscal 2022. A 58% increase in international product sales more than offset weakness in the European market. Meanwhile, US sales remained broadly unchanged.
Net income, on a reported basis, more than doubled year-over-year to $1.6 billion or $1.30 per share during the three-month period. Adjusted earnings climbed to $1.67 per share.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
